WuXi of­fi­cial­ly opens cell and gene ther­a­py site in Philly; An­oth­er mas­sive man­u­fac­tur­ing site comes to NC

A new cell and gene ther­a­py test­ing fa­cil­i­ty in Philadel­phia’s Navy Yard is of­fi­cial­ly opened, WuXi ATU an­nounced Mon­day.

The new fa­cil­i­ty in­cludes 140,000 square feet worth of lab­o­ra­to­ries, and will en­hance the com­pa­ny’s con­tract test­ing, de­vel­op­ment and man­u­fac­tur­ing or­ga­ni­za­tion busi­ness mod­el by tripling the com­pa­ny’s pre­vi­ous ca­pac­i­ty.

The move helps strength­en the ex­ist­ing test­ing ca­pac­i­ty and ca­pa­bil­i­ty, and com­bines the com­pa­ny’s pow­er­ful test­ing ca­pa­bil­i­ties with its ad­vanced ther­a­pies’ process de­vel­op­ment and man­u­fac­tur­ing plat­forms, such as TES­SA tech­nol­o­gy for AAV man­u­fac­tur­ing and XLen­ti sta­ble so­lu­tions for lentivi­ral man­u­fac­tur­ing, it says in a press re­lease.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.